Meeting
2021 ASCO Annual Meeting
Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers.
Authors
David Haan
Bluestar Genomics, San Diego, CA
David Haan , Anna Bergamaschi , Yuhong Ning , William Gibb , Michael Kesling , Adriana Pitea , Maryam Nabiyouni , Chris Ellison , Roger Malta , Albert Nguyen , Gulfem Guler , Erin McCarthy , Tierney Phillips , Aaron Scott , Kyle Hazen , Judy Sheard , Melissa Peters , Kelly Bethel , Wayne Volkmuth , Samuel Levy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3044)
DOI
10.1200/JCO.2021.39.15_suppl.3044
Abstract #
3044
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Clinical validation of Northstar Select, a novel liquid biopsy assay for comprehensive genomic profiling of solid tumors.
First Author: Xavier Bower
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu
Poster
2023 ASCO Annual Meeting
Liquid-biopsy detection of FGFR2 and other actionable rearrangements in GI malignancies.
First Author: Pashtoon Murtaza Kasi
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA-based genomic landscape of early-onset pancreatic cancer.
First Author: Reagan Barnett